TELADOC HEALTH INC (TDOC) Stock Fundamental Analysis

NYSE:TDOC • US87918A1051

5.26 USD
-0.09 (-1.68%)
At close: Feb 27, 2026
5.25 USD
-0.01 (-0.19%)
After Hours: 2/27/2026, 8:04:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to TDOC. TDOC was compared to 35 industry peers in the Health Care Technology industry. The financial health of TDOC is average, but there are quite some concerns on its profitability. TDOC does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

  • TDOC had negative earnings in the past year.
  • TDOC had a positive operating cash flow in the past year.
  • TDOC had negative earnings in each of the past 5 years.
  • Of the past 5 years TDOC 4 years had a positive operating cash flow.
TDOC Yearly Net Income VS EBIT VS OCF VS FCFTDOC Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -5B -10B

1.2 Ratios

  • Looking at the Return On Assets, with a value of -7.75%, TDOC is in the better half of the industry, outperforming 62.86% of the companies in the same industry.
  • With a decent Return On Equity value of -16.03%, TDOC is doing good in the industry, outperforming 65.71% of the companies in the same industry.
Industry RankSector Rank
ROA -7.75%
ROE -16.03%
ROIC N/A
ROA(3y)-115.95%
ROA(5y)-70.6%
ROE(3y)-222.82%
ROE(5y)-134.84%
ROIC(3y)N/A
ROIC(5y)N/A
TDOC Yearly ROA, ROE, ROICTDOC Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 -100 -200 -300 -400 -500

1.3 Margins

  • TDOC has a Gross Margin of 69.80%. This is in the better half of the industry: TDOC outperforms 71.43% of its industry peers.
  • TDOC's Gross Margin has been stable in the last couple of years.
  • The Profit Margin and Operating Margin are not available for TDOC so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 69.8%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.33%
GM growth 5Y1.2%
TDOC Yearly Profit, Operating, Gross MarginsTDOC Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -200 -400

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

4

2. Health

2.1 Basic Checks

  • TDOC does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • TDOC has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
TDOC Yearly Shares OutstandingTDOC Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M
TDOC Yearly Total Debt VS Total AssetsTDOC Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B

2.2 Solvency

  • Based on the Altman-Z score of -6.64, we must say that TDOC is in the distress zone and has some risk of bankruptcy.
  • With a Altman-Z score value of -6.64, TDOC is not doing good in the industry: 80.00% of the companies in the same industry are doing better.
  • The Debt to FCF ratio of TDOC is 7.10, which is on the high side as it means it would take TDOC, 7.10 years of fcf income to pay off all of its debts.
  • TDOC has a Debt to FCF ratio (7.10) which is comparable to the rest of the industry.
  • TDOC has a Debt/Equity ratio of 0.71. This is a neutral value indicating TDOC is somewhat dependend on debt financing.
  • TDOC's Debt to Equity ratio of 0.71 is on the low side compared to the rest of the industry. TDOC is outperformed by 80.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.71
Debt/FCF 7.1
Altman-Z -6.64
ROIC/WACCN/A
WACC6.42%
TDOC Yearly LT Debt VS Equity VS FCFTDOC Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5B 10B 15B

2.3 Liquidity

  • TDOC has a Current Ratio of 2.70. This indicates that TDOC is financially healthy and has no problem in meeting its short term obligations.
  • The Current ratio of TDOC (2.70) is better than 62.86% of its industry peers.
  • A Quick Ratio of 2.60 indicates that TDOC has no problem at all paying its short term obligations.
  • With a Quick ratio value of 2.60, TDOC perfoms like the industry average, outperforming 60.00% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.7
Quick Ratio 2.6
TDOC Yearly Current Assets VS Current LiabilitesTDOC Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

1

3. Growth

3.1 Past

  • The Earnings Per Share has grown by an nice 8.06% over the past year.
EPS 1Y (TTM)8.06%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%50%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%0.28%

3.2 Future

  • TDOC is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 7.37% yearly.
  • TDOC is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 2.77% yearly.
EPS Next Y31.24%
EPS Next 2Y17.3%
EPS Next 3Y9.57%
EPS Next 5Y7.37%
Revenue Next Year1.01%
Revenue Next 2Y1.43%
Revenue Next 3Y2.64%
Revenue Next 5Y2.77%

3.3 Evolution

TDOC Yearly Revenue VS EstimatesTDOC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 1B 2B 3B
TDOC Yearly EPS VS EstimatesTDOC Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 -10 -20 -30 -40 -50

More info and screens

Find the best growth stocksShow best growing peers

2

4. Valuation

4.1 Price/Earnings Ratio

  • TDOC reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Also next year TDOC is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
TDOC Price Earnings VS Forward Price EarningsTDOC Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, TDOC is valued cheaply inside the industry as 91.43% of the companies are valued more expensively.
  • TDOC's Price/Free Cash Flow ratio is rather cheap when compared to the industry. TDOC is cheaper than 94.29% of the companies in the same industry.
Industry RankSector Rank
P/FCF 6.67
EV/EBITDA 6.66
TDOC Per share dataTDOC EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y17.3%
EPS Next 3Y9.57%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • No dividends for TDOC!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

TELADOC HEALTH INC

NYSE:TDOC (2/27/2026, 8:04:00 PM)

After market: 5.25 -0.01 (-0.19%)

5.26

-0.09 (-1.68%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)02-25
Earnings (Next)04-28
Inst Owners71.96%
Inst Owner Change5.45%
Ins Owners0.55%
Ins Owner Change2.04%
Market Cap932.86M
Revenue(TTM)N/A
Net Income(TTM)-223.18M
Analysts67.65
Price Target8.88 (68.82%)
Short Float %15.93%
Short Ratio4.82
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)12.74%
Min EPS beat(2)-3.18%
Max EPS beat(2)28.67%
EPS beat(4)1
Avg EPS beat(4)-10.77%
Min EPS beat(4)-54.19%
Max EPS beat(4)28.67%
EPS beat(8)4
Avg EPS beat(8)3.56%
EPS beat(12)7
Avg EPS beat(12)-763.36%
EPS beat(16)10
Avg EPS beat(16)-740.69%
Revenue beat(2)0
Avg Revenue beat(2)-1.19%
Min Revenue beat(2)-1.88%
Max Revenue beat(2)-0.51%
Revenue beat(4)0
Avg Revenue beat(4)-1.14%
Min Revenue beat(4)-1.88%
Max Revenue beat(4)-0.35%
Revenue beat(8)0
Avg Revenue beat(8)-1.53%
Revenue beat(12)0
Avg Revenue beat(12)-1.49%
Revenue beat(16)0
Avg Revenue beat(16)-1.45%
PT rev (1m)-3%
PT rev (3m)-5.64%
EPS NQ rev (1m)0%
EPS NQ rev (3m)1.04%
EPS NY rev (1m)0%
EPS NY rev (3m)-1.81%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.02%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.37
P/FCF 6.67
P/OCF 3.19
P/B 0.67
P/tB N/A
EV/EBITDA 6.66
EPS(TTM)-1.14
EYN/A
EPS(NY)-0.78
Fwd EYN/A
FCF(TTM)0.79
FCFY15%
OCF(TTM)1.65
OCFY31.37%
SpS14.26
BVpS7.85
TBVpS-1.28
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -7.75%
ROE -16.03%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 69.8%
FCFM 5.53%
ROA(3y)-115.95%
ROA(5y)-70.6%
ROE(3y)-222.82%
ROE(5y)-134.84%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.33%
GM growth 5Y1.2%
F-Score5
Asset Turnover0.88
Health
Industry RankSector Rank
Debt/Equity 0.71
Debt/FCF 7.1
Debt/EBITDA 5.52
Cap/Depr 42.59%
Cap/Sales 6.04%
Interest Coverage N/A
Cash Conversion 162.37%
Profit Quality N/A
Current Ratio 2.7
Quick Ratio 2.6
Altman-Z -6.64
F-Score5
WACC6.42%
ROIC/WACCN/A
Cap/Depr(3y)48.66%
Cap/Depr(5y)42.76%
Cap/Sales(3y)6.01%
Cap/Sales(5y)4.71%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)8.06%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%50%
EPS Next Y31.24%
EPS Next 2Y17.3%
EPS Next 3Y9.57%
EPS Next 5Y7.37%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%0.28%
Revenue Next Year1.01%
Revenue Next 2Y1.43%
Revenue Next 3Y2.64%
Revenue Next 5Y2.77%
EBIT growth 1Y9.06%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year141.73%
EBIT Next 3Y35.28%
EBIT Next 5Y20.45%
FCF growth 1Y25.14%
FCF growth 3Y9.25%
FCF growth 5Y54.93%
OCF growth 1Y2.49%
OCF growth 3Y14.82%
OCF growth 5Y57.92%

TELADOC HEALTH INC / TDOC FAQ

What is the ChartMill fundamental rating of TELADOC HEALTH INC (TDOC) stock?

ChartMill assigns a fundamental rating of 2 / 10 to TDOC.


What is the valuation status for TDOC stock?

ChartMill assigns a valuation rating of 2 / 10 to TELADOC HEALTH INC (TDOC). This can be considered as Overvalued.


How profitable is TELADOC HEALTH INC (TDOC) stock?

TELADOC HEALTH INC (TDOC) has a profitability rating of 2 / 10.


How financially healthy is TELADOC HEALTH INC?

The financial health rating of TELADOC HEALTH INC (TDOC) is 3 / 10.